Reducing Risk Starts with How Content Is Managed
Regulatory compliance in pharma hinges on accuracy, traceability, and auditability—none of which are guaranteed in traditional document-based environments. Inconsistent updates, duplicate content, and siloed versioning create operational risk, delay, and exposure.
Docuvera mitigates these risks by structuring content at the component level, enabling controlled reuse, real-time traceability, and confident alignment with local and global regulations.
How Structured Content Enhances Compliance
Component-Level Audit Trails
Every content unit has its own history—who changed it, why, when, and where it’s used. This enables precise impact assessment during health authority queries, safety updates, or labeling revisions.
Controlled Reuse with Governance
By eliminating uncontrolled copy/paste workflows, Docuvera ensures consistent content is reused across dossiers, labels, and safety documents—with ownership, metadata, and workflows intact.
Regional Variation Management
Create a single source of truth with the flexibility to manage region-specific requirements, supporting simultaneous submissions and global harmonization without introducing risk.
Supporting Today’s Compliance Standards—And Tomorrow’s
Docuvera is built to support:
- GxP compliance (21 CFR Part 11, Annex 11, etc.)
- Regional labeling requirements (EMA, FDA, PMDA, etc.)
- Structured product labeling (SPL, QRD templates, etc.)
- Upcoming frameworks like eCTD 4.0, DADI, and ePI
We partner with organizations to strengthen compliance infrastructure, reduce manual remediation, and accelerate readiness for evolving mandates.